[Markers of thrombotic disease: procoagulant microparticles].
Thrombosis remains one of the leading causes of mortality and morbidity in developed countries. Relevant markers of the primary thrombotic risk however remain of limited accessibility, and clinicians are left with markers of essentially etiological nature. Fortunately, new entities, testifying to cellular activation or damage within the vascular compartment, have been recently described and are in the validation process. Microparticles (MP) are plasma membrane fragments released by stimulated or apoptotic cells. In the vascular compartment, they constitute a disseminated storage pool of bioactive effectors involved in inflammation, thrombosis, vascular tone, angiogenesis. Their biological characteristics are predetermined by the cytosolic and membraneous components hijacked from the activated cells. Their procoagulant properties are based on, (i) the accessibility of phosphatidylserine, a procoagulant aminophospholipid exposed after stimulation and necessary for the assembly of the blood clotting enzyme complexes, and (ii) the possible presence of tissue factor, the major initiator of the coagulation cascade. The incidence of MP in haemostatic processes has been demonstrated in physiology and pathology. They are now considered true pathogenic markers of the thrombotic risk.
Morel
O
O
Unité 143 Inserm, Hôpital de Bicêtre, France.
Toti
F
F
Freyssinet
J-M
JM
D000818:Animals; D015415:Biomarkers; D001808:Blood Vessels / Q000737:chemistry / Q000648:ultrastructure; D002462:Cell Membrane / Q000737:chemistry*; D006801:Humans; D012306:Risk; D013927:Thrombosis / Q000097:blood* / Q000453:epidemiology
D015415:Biomarkers